Chunli Medical (01858) announced interim results. Net profit to mother of 79.0261 million yuan decreased by 37.32% year-on-year

According to the Zhitong Finance App, Chunli Healthcare (01858) announced interim results for the six months ended June 30, 2024. The group achieved operating income of RMB 380 million (same unit), a year-on-year decrease of 29.7%; net profit attributable to shareholders of the parent company was 79.0261 million yuan, a year-on-year decrease of 37.32%; and earnings per share of 0.21 yuan.

According to the announcement, the decline in operating income was mainly due to the impact of the implementation of volume procurement of high-value consumables in the country and a drop in sales prices for the company's related products.

For the six months ended June 30, 2024, the company's gross profit was about 272 million yuan, down 30.54% from about 391 million yuan in the same period last year, mainly due to the impact of the implementation of volume procurement of high-value consumables in the country and a drop in sales prices for the company's related products.